Bolt Biotherapeutics(DE:6LP0)
€5.180.00 (0.00%)
DE:6LP0
Bolt Biotherapeutics earnings date
€5.18
At close:0.00 (0.00%)
Bolt Biotherapeutics (6LP0) Q4 2021 Earnings Report
0 Followers
DE:6LP0 Q4 2021 EPS Results
- Actual EPS
- -EUR 13.28
- Consensus EPS
- -EUR 14.70
- Beat/Miss
- Beat by +EUR 1.42
- One Year Ago EPS
- -EUR 265.10
DE:6LP0 Q4 2021 Revenue Results
- Actual Revenue
- EUR 462.15K
- Expected Revenue
- EUR 341.15K
- Beat/Miss
- Beat by +EUR 121.00K
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2021
- Date
- 03/30/2022
- Time
- After Close
- Conference Call
- Wednesday, March 30, 2022
DE:6LP0 Upcoming Earnings
Bolt Biotherapeutics's next earnings date is estimated for March 31, 2027, based on past reporting schedules.
Q4 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:6LP0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 31, 2027 | 2026 (Q4) | -5.29- | -3.49 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -3.35-2.05 | -3.38 | 39.52% (+1.34) | |
| Aug 11, 2026 | 2026 (Q2) | -3.08-4.16 | -4.06 | -2.47% (-0.10) | |
| May 12, 2026 | 2026 (Q1) | -2.59-3.92 | -5.28 | 25.69% (+1.36) | |
| Mar 12, 2026 | 2025 (Q4) | -5.56-3.49 | -7.64 | 54.29% (+4.15) | |
| Nov 12, 2025 | 2025 (Q3) | -5.16-3.38 | -7.28 | 53.50% (+3.89) | |
| Aug 14, 2025 | 2025 (Q2) | -5.73-4.06 | -10.19 | 60.18% (+6.13) | |
| May 12, 2025 | 2025 (Q1) | -6.46-5.28 | -5.09 | -3.57% (-0.18) | |
| Mar 24, 2025 | 2024 (Q4) | -6.91-7.64 | -8.55 | 10.64% (+0.91) | |
| Nov 12, 2024 | 2024 (Q3) | -6.19-7.28 | -7.82 | 6.98% (+0.55) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

